Membrane mimetic surface functionalization of nanoparticles: Methods and applications

Advances in Colloid and Interface Science

Volumn 197-198, Issue , 2013, Pages 68-84

  Weingart, Jacob ^a   Vabbilisetty, Pratima ^a   Sun, Xue Long ^a,b  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b Cleveland State University   (United States)

Author keywords

Bioimaging; Biosensing; Drug delivery; Lipid; Membrane mimetic; Nanoparticle

Indexed keywords

BIOCOMPATIBILITY; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DRUG DELIVERY; LIPIDS; MEDICAL APPLICATIONS; MEMBRANE STRUCTURES; MEMBRANES; MOLECULAR BIOLOGY; NANOPARTICLES; PHOSPHOLIPIDS;

ARTIFICIAL CELL MEMBRANE; BIO-IMAGING; BIOLOGICAL COMPATIBILITY; BIOMEDICAL APPLICATIONS; BIOSENSING; DRUG DELIVERY APPLICATIONS; PHYSICAL AND CHEMICAL PROPERTIES; SURFACE FUNCTIONALIZATION;

TARGETED DRUG DELIVERY;

BIOMATERIAL; LIPID; NANOPARTICLE; PHOSPHOLIPID; POLYMER;

ARTICLE; BIOIMAGING; BIOMIMETICS; BIOSENSING; CHEMISTRY; DRUG DELIVERY SYSTEM; MEMBRANE-MIMETIC; PARTICLE SIZE; SURFACE PROPERTY;

BIOIMAGING; BIOSENSING; DRUG DELIVERY; LIPID; MEMBRANE-MIMETIC; NANOPARTICLE;

BIOCOMPATIBLE MATERIALS; BIOMIMETICS; NANOPARTICLES; PARTICLE SIZE; PHOSPHOLIPIDS; POLYMERS; SURFACE PROPERTIES;

EID: 84881543662     PISSN: 00018686     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cis.2013.04.003     Document Type: Review

References (145)

1. Senarath-Yapa MD, Phimphivong S, Coym JW, Wirth MJ, Aspinwall CA, Saavedra S. Preparation and characterization of poly(lipid)-coated, fluorophore-doped silica nanoparticles for biolabeling and cellular imaging. Langmuir 2007;23: 12624-33. (Pubitemid 350275581)
2. Senpan A, Caruthers SD, Rhee I, Mauro NA, Pan D, Hu G, et al. Conquering the dark side: colloidal iron oxide nanoparticles. ACS Nano 2009;3(12):3917-26.
3. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002;298:1759-62. (Pubitemid 35404113)
4. Liu Y, Li K, Pan J, Liu B, Feng SS. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials 2010;31:330-8.
5. Cinteza LO, Ohulchanskyy TY, Sahoo Y, Bergey EJ, Pandey RK, Prasad PN. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 2006;3:415-23. (Pubitemid 44351924)
6. Wang X, Liu LH, Ramström O, Yan M. Engineering nanomaterial surfaces for biomedical applications. Exp Biol Med 2009;234:1128-39.
7. Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012;112:5818-78.
8. Mout R, Moyano DF, Rana S, Rotello VM. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 2012;41:2539-44.
9. Thanh NTK, Green LAW. Functionalization of nanoparticles for biomedical applications. Nanotoday 2010;5:213-30.
10. Mulder WJM, Strijkers GJ, van Tilborg GAF, Cormode DP, Fayad ZA, Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 2009;42:904-14.
11. Matsuno R, Ishihara K. Integrated functional nanocolloids covered with artificial cell membranes for biomedical applications. Nanotoday 2011;6:61-74.
12. Gong YK, Winnik FM. Strategies in biomimetic surface engineering of nanoparticles for biomedical applications. Nanoscale 2012;4:360-8.
13. Gupta AK, GuptaM. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995-4021. (Pubitemid 40044762)
14. ArrueboM, Fernandez-Pacheco R, IbarraMR, Santamaria J.Magnetic nanoparticles for drug delivery. Nanotoday 2007;2:22-32. (Pubitemid 46695431)
15. Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2003;36:167-81.
16. Wang YXJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-31. (Pubitemid 33041104)
17. Roca AG, Morales MP, Grady KO, Serna CJ. Structural and magnetic properties of uniform magnetite nanoparticles prepared by high temperature decomposition of organic precursors. Nanotechnology 2006;17:2783-8. (Pubitemid 43814928)
18. Qiao R, Yang C, Gao M. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. J Mater Chem 2009;19:6274-93.
19. Laurent S, Forge D, Port M. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008;108:2064-110.
20. Shtykova EV, Huang X, Remmes N, Baxter D, Stein B, Dragnea B, et al. Structure and properties of iron oxide nanoparticles encapsulated by phospholipids with poly (ethylene glycol) tails. J Phys Chem C 2007;111:18078-86.
21. Park J, An K, Hwang Y, Park JG, Noh HJ, Kim JY, et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004;3:891-5.
22. Sahoo Y, Goodarzi A, Swihart MT, Ohulchanskyy TY, Kaur N, Furlani EP, et al. Aqueous ferrofluid of magnetite nanoparticles: fluorescence labeling and magnetophoretic control. J Phys Chem B 2005;109:3879-85. (Pubitemid 40402267)
23. Bronstein LM, Huang X, Retrum J, Schmucker A, Pink M, Stein BD, et al. Influence of iron oleate complex structure on iron oxide nanoparticle formation. Chem Mater 2007;19:3624-32. (Pubitemid 47210195)
24. Yue-Jian C, Juan T, Fei X, Jia-Bi Z, Ning G, Yi-Hua Z, et al. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev Ind Pharm 2010;36:1235-44.
25. Husein MM, Nassar NN. Nanoparticle preparation using the single microemulsions scheme. Curr Nanosci 2008;4:370-80.
26. Lopez-Perez JA, Lopez-Quintela MA, Mira J, Rivas J, Charles SW. Advances in the preparation of magnetic nanoparticles by the microemulsion method. J Phys Chem B 1997;101:8045-7.
27. Kievit FM, Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 2011;44:853-62.
28. Jun YW, Lee JH, Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed 2008;47:5122-35.
29. Nitin N, LaConte LE, Zurkiya O, Hu X, Bao G. Functionalization of peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem 2004;6:706-12. (Pubitemid 39279249)
30. Lee N, Choi Y, Lee Y, Park M, Moon WK, Choi SH, et al. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r2 relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett 2012;12:3127-31.
31. Glaus C, Rossin R, Welch MJ, Bao G. In vivo evaluation of 64Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem 2010;21: 715-22.
32. Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasoundmediated intracellular delivery and nuclear trafficking. Mol Pharm 2010;7:1959-73.
33. Silva AC, Oliveira TR,Mamani JB,Malheiros SMF,Malavolta L, Pavon LF, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine 2011;6:591-603.
34. Zhang G, Liao Y, Baker I. Surface engineering of core/shell iron/iron oxide nanoparticles from microemulsions for hyperthermia. Mater Sci Eng C 2010;30:92-7.
35. van Tilborg GAF, Cormode DP, Jarzyna PA, van der Toorn A, van der Pol SMA, van Bloois L, et al. Nanoclusters of iron oxide: effect of core composition on structure, biocompatibility, and cell labeling efficacy. Bioconjug Chem 2012;23:941-50.
36. Al-Jamal WT, Kostarelos K. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. Nanomedicine 2007;2:85-98. (Pubitemid 46845780)
37. Zhang Y, Kohler N, Zhang M. Surfacemodification of superparamagneticmagnetite nanoparticles and their intracellular uptake. Biomaterials 2002;23:1553-61. (Pubitemid 34158578)
38. Depalo N, Carrieri P, Comparelli R, Striccoli M, Agostiano A, Bertinetti L, et al. Biofunctionalization of anisotropic nanocrystalline semiconductor-magnetic heterostructures. Langmuir 2011;27:6962-70.
39. Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience 2004;3:66-73.
40. Kaaki K, Herve-Aubert K, Chiper M, Shkilnyy A, Souce M, Benoit R, et al. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting. Langmuir 2012;28:1496-505.
41. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 2011;6:715-28.
42. Huang HC, Chang PY, Chang K, Chen CY, Lin CW, Chen JH, et al. Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging. J Biomed Sci 2009;16:86-95.
43. Jarzyna PA, Deddens LH, Kann BH, Ramachandran S, Calcagno C, ChenW, et al. Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging. Neoplasia 2012;14:964-73.
44. LaConte LEW, Nitin N, Zurkiya O, Caruntu D, O'Connor CJ, Hu X, et al. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity. J Magn Reson Imaging 2007;26:1634-41. (Pubitemid 350291293)
45. Tong S,Hou S, Zheng Z, Zhou J, BaoG. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett 2010;10:4607-13.
46. Baer DR, Gaspar DJ, Nachimuthu P, Techane SD, Castner DG. Application of surface chemical analysis tools for characterization of nanoparticles. Anal Bioanal Chem 2010;396:983-1002.
47. Hultman KL, Raffo AJ, Grzenda AL, Harris PE, Brown TR, O'Brien S. Magnetic resonance imaging of major histocompatibility class ii expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles. ACS Nano 2008;2:477-84.
48. Cormode DP, Skajaa GO, Delshad A, Parker N, Jarzyna PA, Calcagno C, et al. A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. Bioconjug Chem 2011;22(3):353-61.
49. Huang X, Bronstein LM, Retrum J, Dufort C, Tsvetkova I, Aniagyei S, et al. Self-assembled virus-like particles with magnetic cores. Nano Lett 2007;7(8): 2407-16. (Pubitemid 47310139)
50. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006;19:142-64. (Pubitemid 43250800)
51. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 2001;7:1241-4. (Pubitemid 33063780)
52. van Tilborg GA, Mulder WJ, Deckers N, Storm G, Reutelingsperger CPM, Strijkers GJ, et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem 2006;17:741-9. (Pubitemid 43794385)
53. Wahajuddin Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 2012;7:3445-71.
54. Edmund AR, Kambalapally S, Wilson TA, Nicolosi RJ. Encapsulation of cadmium selenide quantum dots using a self-assembling nanoemulsion (SANE) reduces their in vitro toxicity. Toxicol In Vitro 2011;25:185-90.
55. Steigerwald ML, Brus LE. Semiconductor crystallites: a class of large molecules. Acc Chem Res 1990;23:183-8.
56. Nirmal M, Brus L. Luminescence photophysics in semiconductor nanocrystals. Acc Chem Res 1999;32:407-14.
57. Sharma CVK. Crystal engineering-where do we go from here? Cryst Growth Des 2002;2:467.
58. Kikkeri R, Laurino P, Odedra A, Seeberger PH. Synthesis of carbohydratefunctionalized quantum dots in microreactors. Angew Chem Int Ed 2010;49:2054.
59. Willard DM, Carillo LL, Jung J, Van Orden A. CdSe-ZnS Quantum dots as resonance energy transfer donors in a model protein-protein binding assay. Nano Lett 2001;1:469-74. (Pubitemid 33673968)
60. Peralta-Videa JR, Zhao L, Lopez-MorenoML, de la Rosa G,Hong J, Gardea-Torresdey JL. Nanomaterials and the environment: a review for the biennium2008-2010. J Hazard Mater 2011;186:1-15.
61. Murray CB,NorrisDJ, BawendiMG. Synthesis and characterization of nearlymonodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am Chem Soc 1993;115:8706-15.
62. Bowen-Katari JE, Colvin VL, Alivisatos AP. X-ray photoelectron spectroscopy of CdSe nanocrystals with applications to studies of the nanocrystal surface. J Phys Chem 1994;98:4109-17.
63. Ramachandran S, Kumar GL, Blick RH, van der Weide DW. Current bursts in lipid bilayers initiated by colloidal quantum dots. Appl Phys Lett 2005;86: 083901.
64. Yan M, Zhang Y, Xu K, Fu T, Qin H, Zheng X. An in vitro study of vascular endothelial toxicity of CdTe quantum dots. Toxicology 2011;282:94-103.
65. Rogach AL, Kornowski A, Gao MY, Eychmuller A, Weller H. Synthesis and characterization of a size series of extremely small thiol-stabilized CdSe nanocrystals. J Phys Chem B 1999;103:3065-9. (Pubitemid 129702439)
66. Gerion D, Pinaud F, Williams SC, Parak WJ, Zanchet D, Weiss S, et al. Synthesis and properties of biocompatible water-soluble silica-coated CdSe/ZnS semiconductor quantum dots. J Phys Chem B 2001;105:8861-71. (Pubitemid 35338761)
67. Yang XT, Zhang Y. Encapsulation of quantum nanodots in polystyrene and silica micro-/nanoparticles. Langmuir 2004;20:6071-3.
68. Chen YF, Rosenzweig Z. Luminescent CdSe quantum dot doped stabilized micelles. Nano Lett 2002;2:1299-302. (Pubitemid 135706515)
69. De GC, Roy AM, Saba S, Aditya SJ. Semiconductor nanoparticles (CdS, ZnS and ZnxCdS1 - x) in reverse micellar media. J Ind Chem Soc 2003;80:551-7. (Pubitemid 37051881)
70. FanH, Leve EW, Scullin C,Gabaldon J, TallantD, Bunge S, et al. Surfactant-assisted synthesis of water-soluble and biocompatible semiconductor quantum dot micelles. Nano Lett 2005;5:645-8. (Pubitemid 40609734)
71. Murcia MJ, Minner DE, Mustata GM, Ritchie K, Naumann CA. Design of quantum dot-conjugated lipids for long-term, high-speed tracking experiments on cell surfaces. J Am Chem Soc 2008;130:15054-62.
72. Skajaa T, Zhao Y, van den Heuvel DJ, Gerritsen HC, Cormode DP, Koole R, et al. Quantum dot and Cy5.5 labeled nanoparticles to investigate lipoprotein biointeractions via förster resonance energy transfer. Nano Lett 2010;10:5131-8.
73. Sigot V, Arndt-Jovin DJ, Jovin TM. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. Bioconjug Chem 2010;21:1465-72.
74. Luccardini C, Tribet C, Vial F, Marchi-Artzner V, Dahan M. Size, charge, and interactions with giant lipid vesicles of quantum dots coated with an amphiphilic macromolecule. Langmuir 2006;22:2304-10. (Pubitemid 43382868)
75. Liu W, He Z, Liang J, Zhu Y, Xu H, Yang X. Preparation and characterization of novel fluorescent nanocomposite particles: CdSe/ZnS core-shell quantum dots loaded solid lipid nanoparticles. J Biomed Mater Res 2008;84A:1018-25. (Pubitemid 351295012)
76. Galloway JF, Winter A, Lee KH, Park JH, Dvoracek CM, Devreotes P, et al. Quantitative characterization of the lipid encapsulation of quantum dots for biomedical applications. Nanomedicine 2012;8:1190-9.
77. Johnson RL, Johnson GO, Nurmi JT, Tratnyek PG. Natural organic matter enhanced mobility of nano zerovalent iron. Environ Sci Technol 2009;43:5455-60.
78. Jablonski A, Powell CJ. Information depth and the mean escape depth in Auger electron spectroscopy and x-ray photoelectron spectroscopy. J Vac Sci Technol A 2003;21:274-83.
79. Murcia MJ, Shaw DL, Woodruff H, Naumann CA, Young BY, Long EL. Facile sonochemical synthesis of highly luminescent ZnS-shelled CdSe quantum dots. Chem Mater 2006;18:2219-25. (Pubitemid 43836568)
80. Gopalakrishnan G, Danelon C, Izewska P, Prummer M, Bolinger PY, Geissbuhler I, et al. Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells. Angew Chem Int Ed 2006;45:5478-83. (Pubitemid 44384330)
81. Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006:107459-66.
82. Mulder WJM, Koole R, Brandwijk RJ, Storm G, Chin PTK, Strijkers GJ, et al. Quantum dots with paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006;6(1):1-6. (Pubitemid 43166093)
83. Lin CY, Liu TM, Chen CY, Huang YL, HuangWK, Sun CK, et al. Quantitative and qualitative investigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles fromvasculature in mouse tumors. J Control Release 2010;146:291-8.
84. El-Sayed MA. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 2001;34:257-64. (Pubitemid 32816462)
85. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute toxicity. Small 2005;1:325-7. (Pubitemid 43951781)
86. Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008;41:1721-30.
87. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 2008;26:83-90.
88. Keren S, Zavaleta C, Cheng Z, de la Zerda A, Gheysens O, Gambhir SS. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci U S A 2008;105:5844-9. (Pubitemid 351758460)
89. Turkevitch J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Faraday Soc 1951;11:55-75.
90. Enustun BV, Turkevich J. Coagulation of colloidal gold. J Am Chem Soc 1963;85: 3317-28.
91. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiolderivatized gold nanoparticles in a two-phase liquid-liquid system. J Chem Soc Chem Commun 1994:801-2.
92. Yang JA, Murphy CJ. Evidence for patchy lipid layers on gold nanoparticle surfaces. Langmuir 2012;28:5404-16.
93. Sitaula S, Mackiewicz MR, Reed SM. Gold nanoparticles become stable to cyanide etch when coated with hybrid lipid bilayers. Chem Commun 2008: 3013-5. (Pubitemid 351904554)
94. Mackiewicz MR, Hodges HL, Reed SM. C-reactive protein induced rearrangement of phosphatidylcholine on nanoparticle mimics of lipoprotein particles. J Phys Chem B 2010;114:5556-62.
95. Thaxton CS, Daniel WL, Giljohann DA, Thomas AD,Mirkin CA. Templated spherical high density lipoprotein nanoparticles. J Am Chem Soc 2009;131(4): 1384-5.
96. Genc R, Clergeaud G, Ortiz M, O'Sullivan CK. Green synthesis of gold nanoparticles using glycerol-incorporated nanosized liposomes. Langmuir 2011;27:10894-900.
97. Tam NCM, Scott BTM, Voicu D, Wilson BC, Zheng G. Facile synthesis of Raman active phospholipid gold nanoparticles. Bioconjug Chem 2010;21(12):2178-82.
98. Kong WH, Bae KH, Jo SD, Kim JS, Park TG. Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles. Pharm Res 2012;29:362-74.
99. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008;8:3715-23.
100. Stober W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 1968;26:62-9.
101. Osseoasare K, Arriagada F. Preparation of SiO2 nanoparticles in a nonionic reverse micellar system. J Colloids Surf 1990;50:321-39.
102. Yong KT, Roy I, SwihartMT, Prasad PN.Multifunctional nanoparticles as biocompatible targeted probes for human cancer diagnosis and therapy. J Mater Chem 2009;19: 4655-72.
103. Rai P, Mallidi S, Zheng X, Rahmanzadeh R, Mir Y, Elrington S, et al. Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev 2010;62:1094-124.
104. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, et al. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of lipid coating: a multimodality investigation. Nano Lett 2008;8:2517-25.
105. Kumar R, Roy I, Ohulchanskyy TY, Goswami LN, Bonoiu AC, Bergey EJ, et al. Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2008;2:449-56.
106. Bagwe RP, Hilliard LR, Tan W. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 2006;22:4357-62.
107. Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E. A new class of silica cross-linked micellar core-shell nanoparticles. J Am Chem Soc 2006;128: 6447-53. (Pubitemid 43727283)
108. Yang CY, Cai SJ, Liu H, Pidgeon C. Immobilized artificial membranes - screens for drug membrane interactions. Adv Drug Deliv Rev 1997;23:229-56. (Pubitemid 27047005)
109. Mornet S, Lambert O, Duguet E, Brisson A. The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy. Nano Lett 2005;5:281-5. (Pubitemid 40308285)
110. Radler J, Strey H, Sackmann E. Phenomenology and kinetics of lipid bilayer spreading on hydrophilic surfaces. Langmuir 1995;11:4539-48.
111. Sackmann E. Supported membranes: scientific and practical applications. Science 1996;271:43-8. (Pubitemid 26033275)
112. Carmona-Ribeiro AM. Biomimetic nanoparticles: preparation, characterization and biomedical applications. Int J Nanomedicine 2010;5:249-59.
113. Wang H, Drazenovic J, Luo Z, Zhang J, Zhou H, Wunder SL. Mechanism of supported bilayer formation of zwitterionic lipids on SiO2 nanoparticles and structure of the stable colloids. RSC Adv 2012;2:11336-48.
114. Ahmed S, Savarala S, Chen Y, Bothun G, Wunder SL. Formation of lipid sheaths around nanoparticle-supported lipid bilayers. Small 2012;8:1740-51.
115. Troutier AL, Ladaviere C. An overview of lipid membrane supported by colloidal particles. Adv Colloid Interface Sci 2007;133(1):1-21. (Pubitemid 47301775)
116. Ahmed S, Wunder SL. Effect of high surface curvature on the main phase transition of supported phospholipid bilayers on SiO2 nanoparticles. Langmuir 2009;25:3682-91.
117. Savarala S, Ahmed S, Ilies MA, Wunder SL. Formation and colloidal stability of DMPC supported lipid bilayers on SiO2 nanobeads. Langmuir 2010;26:12081-8.
118. Savarala S, Monson F, Ilies MA, Wunder SL. Supported lipid bilayer nanosystems: stabilization by undulatory-protrusion forces and destabilization by lipid bridging. Langmuir 2011;27:5850-61.
119. Savarala S, Ahmed S, Ilies MA, Wunder SL. Stabilization of soft lipid colloids: competing effects of nanoparticle decoration and supported lipid bilayer formation. ACS Nano 2011;5:2619-28.
120. Liu J, Stace-Naughton A, Jiang X, Brinker CJ. Silica nanoparticle supported lipid bilayers for gene delivery. J Am Chem Soc 2009;131:1354-5.
121. Liu J, Stace-Naughton A, Brinker CJ. Silica nanoparticle supported bilayers for gene delivery. Chem Commun 2009:5100-2.
122. Bringas E, Koysuren O, Quach DV, Mahmoudi M, Aznar E, Roehling JD, et al. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field. Chem Commun 2012;48:5647-9.
123. Roggers RA, Lin VSY, Trewyn BG. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization. Mol Pharm 2012;9:2770-7.
124. Epler K, Padilla D, Phillips G, Crowder P, Castillo R,Wilkinson D, et al. Delivery of ricin toxin A-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. Adv Health Mater 2012;1:348-53.
125. Ashley CE, Carnes EC, Epler KE, Padilla DP, Phillips GK, Castillo RE, et al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticlesupported lipid bilayers. ACS Nano 2012;6:2174-88.
126. Yang Y, Song W, Wang A, Zhu P, Fei J, Li J. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers. Phys Chem Chem Phys 2010;12: 4418-22.
127. Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J Control Release 2009;134:62-70.
128. Simovic S, Hui H, Song Y, Davey AK, Rades T, Prestidge CA. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles. J Control Release 2010;143:367-73.
129. Cauda V, EngelkeH, SauerA,ArcizetD, Brachle C, Radler J, et al. Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake. Nano Lett 2010;10:2484-92.
130. Irvine DJ. Drug delivery: one nanoparticle, one kill. Nat Mater 2011;10:342-3.
131. Goutayer M, Dufort S, Josserand V, Royere A, Heinrich E, Vinet F, et al. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm 2010;75:137-47.
132. Sridaeng D, Weingart JJ, Chantarasiri N, Zhe J, Hu JJ. Postsynthetic surface functionalization, encapsulation, and releasing studies of a novel polymer nanocapsule. J Appl Polym Sci 2010;117:706-13.
133. Yan GP, Hua L, Cheng SX, Bottle SE,Wang XG, Yew YK, et al. Preparation, properties, and mathematical modeling of microparticle drug delivery systems based on biodegradable amphiphilic triblock copolymers. J Appl Polym Sci 2004;92:3869.
134. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharm Rev 2001;53:296.
135. Troutier AL, Delair T, Pichot C, Ladaviere C. Physicochemical and interfacial investigation of lipid/polymer particle assemblies. Langmuir 2005;21:1305-13. (Pubitemid 40275066)
136. Zhang L, Chan JM, Gu FX, Rhee JW, Wang AZ, Radovic-Moreno AF, et al. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008;2:1696-702.
137. Messerschmidt SKE, Musyanovych A, Altvater M, Scheurich P, Pfizenmaier K, Landfester K, et al. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells. J Control Release 2009;137:69-77.
138. Fang RH, Aryal S, Hu CMJ, Zhang L. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir 2010;26:16958-62.
139. Troutier AL, Veron L, Delair T, Pichot C, Ladaviere C. New insights into self-organization of a model lipid mixture and quantification of its adsorption on spherical polymer particles. Langmuir 2005;21:9901-10. (Pubitemid 41541204)
140. De Miguel I, Imbertie L, Rieumajou V, Major M, Kravtzoff R, Betbeder D. Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers. Pharm Res 2000;17:817-24. (Pubitemid 30666962)
141. Gomes JFPS, Rocha S, do Carmo Pereira M, Peres I, Moreno S, Toca-Herrera J, et al. Lipid/particle assemblies based on maltodextrin-gum arabic core as biocarriers. Colloids Surf B 2010;76:449-55.
142. Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, et al. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials 2010;31:8741-8.
143. Zheng Y, Yu B,WeecharangsanW, Piao L, DarbyM,Mao Y, et al. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. Int J Pharm 2010;390:234-341.
144. Fang RH, Chen KNH, Aryal S, Hu CMJ, Zhang K, Zhang L. Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor. Langmuir 2012;28:13824-9.
145. Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membranecamouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A 2011;108:10980-5.